AAPL vs. JNJ: A Head-to-Head Stock Comparison
Here's a clear look at AAPL and JNJ, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | AAPL | JNJ |
|---|---|---|
| Company Name | Apple Inc. | Johnson & Johnson |
| Country | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry Group | Technology Hardware & Equipment | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| GICS Sub-Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| Market Capitalization | 3,656.84 billion USD | 579.46 billion USD |
| Currency | USD | USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | December 12, 1980 | January 2, 1962 |
| Security Type | Common Stock | Common Stock |
AAPL's market capitalization (3,656.84 billion USD) is substantially larger than JNJ's (579.46 billion USD), indicating a significant difference in their market valuations.
Historical Performance
This chart compares the performance of AAPL and JNJ by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | AAPL | JNJ |
|---|---|---|
| 5-Day Price Return | -1.07% | 2.14% |
| 13-Week Price Return | -8.65% | 16.85% |
| 26-Week Price Return | -2.84% | 38.02% |
| 52-Week Price Return | 11.15% | 47.40% |
| Month-to-Date Return | -5.82% | -3.21% |
| Year-to-Date Return | -8.48% | 16.19% |
| 10-Day Avg. Volume | 42.73M | 8.19M |
| 3-Month Avg. Volume | 46.29M | 8.96M |
| 3-Month Volatility | 23.49% | 15.82% |
| Beta | 1.10 | 0.35 |
AAPL's beta of 1.10 points to significantly higher volatility compared to JNJ (beta: 0.35), suggesting AAPL has greater potential for both gains and losses relative to market movements.
Profitability
Return on Equity (TTM)
AAPL
159.94%
Technology Hardware, Storage & Peripherals Industry
- Max
- 62.71%
- Q3
- 29.99%
- Median
- 10.15%
- Q1
- 6.04%
- Min
- -25.52%
AAPL's Return on Equity of 159.94% is exceptionally high, placing it well beyond the typical range for the Technology Hardware, Storage & Peripherals industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.
JNJ
33.78%
Pharmaceuticals Industry
- Max
- 39.28%
- Q3
- 20.27%
- Median
- 12.92%
- Q1
- 6.34%
- Min
- -14.55%
In the upper quartile for the Pharmaceuticals industry, JNJ's Return on Equity of 33.78% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
AAPL
27.04%
Technology Hardware, Storage & Peripherals Industry
- Max
- 19.59%
- Q3
- 9.62%
- Median
- 5.23%
- Q1
- 2.51%
- Min
- -1.17%
AAPL's Net Profit Margin of 27.04% is exceptionally high, placing it well beyond the typical range for the Technology Hardware, Storage & Peripherals industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.
JNJ
28.46%
Pharmaceuticals Industry
- Max
- 41.87%
- Q3
- 22.21%
- Median
- 14.64%
- Q1
- 9.09%
- Min
- -8.35%
A Net Profit Margin of 28.46% places JNJ in the upper quartile for the Pharmaceuticals industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin (TTM)
AAPL
32.38%
Technology Hardware, Storage & Peripherals Industry
- Max
- 22.21%
- Q3
- 11.23%
- Median
- 7.39%
- Q1
- 3.57%
- Min
- -1.25%
AAPL's Operating Profit Margin of 32.38% is exceptionally high, placing it well above the typical range for the Technology Hardware, Storage & Peripherals industry. This demonstrates outstanding efficiency in managing its core operations, which can be a result of strong pricing power or superior cost control.
JNJ
34.59%
Pharmaceuticals Industry
- Max
- 42.93%
- Q3
- 25.68%
- Median
- 18.69%
- Q1
- 12.70%
- Min
- -4.35%
An Operating Profit Margin of 34.59% places JNJ in the upper quartile for the Pharmaceuticals industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | AAPL | JNJ |
|---|---|---|
| Return on Equity (TTM) | 159.94% | 33.78% |
| Return on Assets (TTM) | 33.62% | 13.76% |
| Net Profit Margin (TTM) | 27.04% | 28.46% |
| Operating Profit Margin (TTM) | 32.38% | 34.59% |
| Gross Profit Margin (TTM) | 47.33% | 67.92% |
Financial Strength
Current Ratio (MRQ)
AAPL
0.97
Technology Hardware, Storage & Peripherals Industry
- Max
- 3.32
- Q3
- 2.03
- Median
- 1.46
- Q1
- 1.17
- Min
- 0.70
AAPL's Current Ratio of 0.97 falls into the lower quartile for the Technology Hardware, Storage & Peripherals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
JNJ
1.03
Pharmaceuticals Industry
- Max
- 6.79
- Q3
- 3.64
- Median
- 2.17
- Q1
- 1.38
- Min
- 0.80
JNJ's Current Ratio of 1.03 falls into the lower quartile for the Pharmaceuticals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
AAPL
1.03
Technology Hardware, Storage & Peripherals Industry
- Max
- 1.03
- Q3
- 0.77
- Median
- 0.29
- Q1
- 0.14
- Min
- 0.00
AAPL's leverage is in the upper quartile of the Technology Hardware, Storage & Peripherals industry, with a Debt-to-Equity Ratio of 1.03. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
JNJ
0.59
Pharmaceuticals Industry
- Max
- 1.60
- Q3
- 0.76
- Median
- 0.28
- Q1
- 0.03
- Min
- 0.00
JNJ's Debt-to-Equity Ratio of 0.59 is typical for the Pharmaceuticals industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
AAPL
622.51
Technology Hardware, Storage & Peripherals Industry
- Max
- 41.25
- Q3
- 29.14
- Median
- 8.92
- Q1
- 2.73
- Min
- -23.93
With an Interest Coverage Ratio of 622.51, AAPL demonstrates a superior capacity to service its debt, placing it well above the typical range for the Technology Hardware, Storage & Peripherals industry. This stems from either robust earnings or a conservative debt load.
JNJ
34.01
Pharmaceuticals Industry
- Max
- 154.61
- Q3
- 67.33
- Median
- 13.25
- Q1
- 2.96
- Min
- -27.02
JNJ's Interest Coverage Ratio of 34.01 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | AAPL | JNJ |
|---|---|---|
| Current Ratio (MRQ) | 0.97 | 1.03 |
| Quick Ratio (MRQ) | 0.94 | 0.69 |
| Debt-to-Equity Ratio (MRQ) | 1.03 | 0.59 |
| Interest Coverage Ratio (TTM) | 622.51 | 34.01 |
Growth
Revenue Growth
Revenue Growth at a Glance
| Symbol | AAPL | JNJ |
|---|---|---|
| Revenue Growth (MRQ vs Prior YoY) | 15.65% | 9.08% |
| Revenue Growth (TTM vs Prior YoY) | 10.07% | 6.05% |
| 3-Year Revenue CAGR | 1.81% | 5.60% |
| 5-Year Revenue CAGR | 8.68% | 2.67% |
EPS Growth
EPS Growth at a Glance
| Symbol | AAPL | JNJ |
|---|---|---|
| EPS Growth (MRQ vs Prior YoY) | 18.54% | 48.50% |
| EPS Growth (TTM vs Prior YoY) | 25.65% | 90.56% |
| 3-Year EPS CAGR | 6.89% | 17.88% |
| 5-Year EPS CAGR | 17.91% | 14.90% |
Dividend
Dividend Yield (TTM)
AAPL
0.42%
Technology Hardware, Storage & Peripherals Industry
- Max
- 6.14%
- Q3
- 3.38%
- Median
- 1.91%
- Q1
- 0.03%
- Min
- 0.00%
AAPL's Dividend Yield of 0.42% is consistent with its peers in the Technology Hardware, Storage & Peripherals industry, providing a dividend return that is standard for its sector.
JNJ
2.14%
Pharmaceuticals Industry
- Max
- 6.35%
- Q3
- 3.00%
- Median
- 1.84%
- Q1
- 0.00%
- Min
- 0.00%
JNJ's Dividend Yield of 2.14% is consistent with its peers in the Pharmaceuticals industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
AAPL
13.15%
Technology Hardware, Storage & Peripherals Industry
- Max
- 136.56%
- Q3
- 69.54%
- Median
- 38.88%
- Q1
- 0.00%
- Min
- 0.00%
AAPL's Dividend Payout Ratio of 13.15% is within the typical range for the Technology Hardware, Storage & Peripherals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
JNJ
46.19%
Pharmaceuticals Industry
- Max
- 188.03%
- Q3
- 80.63%
- Median
- 44.08%
- Q1
- 0.00%
- Min
- 0.00%
JNJ's Dividend Payout Ratio of 46.19% is within the typical range for the Pharmaceuticals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | AAPL | JNJ |
|---|---|---|
| Dividend Yield (TTM) | 0.42% | 2.14% |
| Dividend Payout Ratio (TTM) | 13.15% | 46.19% |
Valuation
Price-to-Earnings Ratio (TTM)
AAPL
31.01
Technology Hardware, Storage & Peripherals Industry
- Max
- 31.01
- Q3
- 23.25
- Median
- 14.04
- Q1
- 12.10
- Min
- 7.09
A P/E Ratio of 31.01 places AAPL in the upper quartile for the Technology Hardware, Storage & Peripherals industry. This high valuation relative to peers suggests the market holds elevated expectations for the company's future growth.
JNJ
21.62
Pharmaceuticals Industry
- Max
- 40.21
- Q3
- 26.28
- Median
- 18.77
- Q1
- 14.14
- Min
- 3.46
JNJ's P/E Ratio of 21.62 is within the middle range for the Pharmaceuticals industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
AAPL
8.39
Technology Hardware, Storage & Peripherals Industry
- Max
- 5.32
- Q3
- 2.77
- Median
- 0.92
- Q1
- 0.46
- Min
- 0.03
With a P/S Ratio of 8.39, AAPL trades at a valuation that eclipses even the highest in the Technology Hardware, Storage & Peripherals industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.
JNJ
6.15
Pharmaceuticals Industry
- Max
- 7.19
- Q3
- 4.85
- Median
- 2.51
- Q1
- 1.94
- Min
- 0.83
JNJ's P/S Ratio of 6.15 is in the upper echelon for the Pharmaceuticals industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
Price-to-Book Ratio (MRQ)
AAPL
45.87
Technology Hardware, Storage & Peripherals Industry
- Max
- 9.86
- Q3
- 5.67
- Median
- 1.96
- Q1
- 1.07
- Min
- 0.31
At 45.87, AAPL's P/B Ratio is at an extreme premium to the Technology Hardware, Storage & Peripherals industry. This signifies that the market's valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.
JNJ
6.13
Pharmaceuticals Industry
- Max
- 10.12
- Q3
- 5.02
- Median
- 2.39
- Q1
- 1.54
- Min
- 0.63
JNJ's P/B Ratio of 6.13 is in the upper tier for the Pharmaceuticals industry. This indicates that investors are paying a premium relative to the company's net assets, a valuation that hinges on its ability to generate superior profits.
Valuation at a Glance
| Symbol | AAPL | JNJ |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 31.01 | 21.62 |
| Price-to-Sales Ratio (TTM) | 8.39 | 6.15 |
| Price-to-Book Ratio (MRQ) | 45.87 | 6.13 |
| Price-to-Free Cash Flow Ratio (TTM) | 29.62 | 29.42 |